• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of NASH pathophysiology using glycobiological technique

Research Project

Project/Area Number 20590777
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionOsaka University

Principal Investigator

HIRAMATSU Naoki (2009-2010)  Osaka University, 医学系研究科, 講師 (30362700)

松本 仁 (2008)  Osaka University, 医学系研究科, 助教 (80467505)

Co-Investigator(Kenkyū-buntansha) MATSUMOTO Hitoshi  大阪大学, 医学系研究科, 助教 (80467505)
MIYOSHI Eiji  大阪大学, 医学系研究科, 教授 (20322183)
平松 直樹  大阪大学, 医学系研究科, 助教 (30362700)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywords肝臓学 / 糖鎖 / 脂肪肝 / GnT-V / NASH / MCP-1 / ERストレス / 小胞体ストレス / メタボリックシンドローム
Research Abstract

N-Acetylglucosaminyltransferase V (GnT-V), catalyzing beta1-6 branching in asparagine-linked oligosaccharides, is known to promote cancer metastasis, and its expression is increased in chronic hepatitis (CH) progression. Using GnT-V transgenic (Tg) mice, we found GnT-V prevented hepatic inflammation and fibrosis in a mouse CH model through modulation of lymphocyte and HSC function. Moreover, we also found GnT-V prevented hepatocyte cholesterol accumulation which led to ameliorate hepatocyte sensitivity to inflammation. These results indicated expression of GnT-V in CH would prevent disease progression as a self-defense reaction.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (44 results)

All 2011 2010 2009 2008

All Journal Article (31 results) (of which Peer Reviewed: 31 results) Presentation (13 results)

  • [Journal Article] Pretreatment Prediction of Anemia Progression by Pegylated interferon Alpha-2b Plus Ribavirin Combination Therapy in Chronic Hepatitis C Infection : Decision-Tree Analysis.2011

    • Author(s)
      Hiramatsu N(1番目), Kurosaki M, et. al.
    • Journal Title

      J Gastroenterol in press

    • NAID

      10029706983

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan.2011

    • Author(s)
      Oze T, Hiramatsu N(2番目), et. al.
    • Journal Title

      J Gastroenterol in press

    • NAID

      10029563329

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan.2011

    • Author(s)
      Oze T, Hiramatsu N(2番目), et. al.
    • Journal Title

      J Gastroenterol in press

    • NAID

      10029313419

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.2011

    • Author(s)
      Oze T, Hiramatsu N(2番目), et. al.
    • Journal Title

      J Hepatol 54(4)

      Pages: 604-11

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated by peginterferon and ribavirin therapy.2011

    • Author(s)
      Inoue Y, Hiramatsu N(2番目), et. al.
    • Journal Title

      J Med Virol 83(3)

      Pages: 419-27

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated by peginterferon and ribavirin therapy.2011

    • Author(s)
      Inoue Y, Hiramatsu N, et al.
    • Journal Title

      J Med Virol.

      Volume: 83(3) Pages: 419-27

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.2011

    • Author(s)
      Oze T, Hiramatsu N, et al.
    • Journal Title

      J Hepatol.

      Volume: (In press)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.2010

    • Author(s)
      Matsumoto H(1番目) , Miyoshi E(2番目), et. al.
    • Journal Title

      Clin Chem Lab Med 48(4)

      Pages: 505-12

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.2010

    • Author(s)
      Miyoshi E(1番目), Shinzaki S, Moriwaki K, Matsumoto H(4番目)
    • Journal Title

      Methods Enzymol 478

      Pages: 153-64

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.2010

    • Author(s)
      Hikita H, Hiramatsu N(13番目), et. al.
    • Journal Title

      Hepatology 52(4)

      Pages: 1310-21

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin : reducing drug doses has no impact on rapid and sustained virological responses.2010

    • Author(s)
      Inoue Y, Hiramatsu N(2番目), et. al.
    • Journal Title

      J Viral Hepat 17(5)

      Pages: 336-44

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin : reducing drug doses has no impact on rapid and sustained virological responses.2010

    • Author(s)
      Inoue Y, Hiramatsu N, et al.
    • Journal Title

      J Viral Hepat.

      Volume: 17(5) Pages: 336-44

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.2010

    • Author(s)
      Hikita H, Hiramatsu N, et al.
    • Journal Title

      Hepatology

      Volume: 52(4) Pages: 1310-21

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.2010

    • Author(s)
      Miyoshi E, Matsumoto H, et al.
    • Journal Title

      Methods Enzymol.

      Volume: 478 Pages: 153-64

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.2010

    • Author(s)
      Miyoshi E, Matsumoto H, et al.
    • Journal Title

      Clin Chem Lab Med.

      Volume: 48(4) Pages: 505-12

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice.2009

    • Author(s)
      Ezaki H, Matsumoto H(6番目), et. al.
    • Journal Title

      Biochem Biophys Res Commun. 378(1)

      Pages: 68-72

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization.2009

    • Author(s)
      Fukushima J, Matsumoto H(3番目), et. al.
    • Journal Title

      Hepatol Res 39(7)

      Pages: 724-38

    • NAID

      10025326832

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir.2009

    • Author(s)
      Kurashige N, Hiramatsu N(2番目), et. al.
    • Journal Title

      Antivir Ther 14(6)

      Pages: 873-7

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.2009

    • Author(s)
      Kurashige N, Hiramatsu N(2番目), et. al.
    • Journal Title

      J Gastroenterol 44(8)

      Pages: 864-70

    • NAID

      10025176735

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis.2009

    • Author(s)
      Kurokawa M, Hiramatsu N(2番目), et. al.
    • Journal Title

      Hepatol Res 39(5)

      Pages: 432-8

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2b plus ribavirin.2009

    • Author(s)
      Hiramatsu N(1番目), Oze T, et. al.
    • Journal Title

      J Viral Hepat 16(8)

      Pages: 586-94

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Peginterferon alfa-2b affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with pegylated interferon alfa-2b plus ribavirin.2009

    • Author(s)
      Oze T, Hiramatsu N(2番目), et. al.
    • Journal Title

      J Viral Hepat 16(8)

      Pages: 578-85

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Peginterferon, alfa-2b affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with pegylated interferon alfa-2b plus ribavirin2009

    • Author(s)
      Oze T, Hiramatsu N, et al.
    • Journal Title

      J Viral Hepat. 16(8)

      Pages: 578-85

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2b plus ribavirin2009

    • Author(s)
      Hiramatsu N, Oze T, et al.
    • Journal Title

      J Viral Hepat. 16(8)

      Pages: 586-94

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis2009

    • Author(s)
      Kurokawa M, Hiramatsu N, et al.
    • Journal Title

      Hepatol Res. 39(5)

      Pages: 432-8

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance2009

    • Author(s)
      Kurashige N, Hiramatsu N, et al.
    • Journal Title

      J Gastroenterol. 44(8)

      Pages: 864-70

    • NAID

      10025176735

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir2009

    • Author(s)
      Kurashige N, Hiramatsu N, et al.
    • Journal Title

      Antivir Ther. 14(6)

      Pages: 873-7

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization2009

    • Author(s)
      Fukushima J, Matsumoto H, et al.
    • Journal Title

      Hepatol Res. 39(7)

      Pages: 724-38

    • NAID

      10025326832

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice2009

    • Author(s)
      Ezaki H, Matsumoto H, et al.
    • Journal Title

      Biochem Biophys Res Commun. 378(1)

      Pages: 68-72

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Delayed liver regeneration after partial hepatectomy inadiponectin knockout mice.2009

    • Author(s)
      Ezaki Hisao
    • Journal Title

      Biochemical and Biophysical Research Communications 378

      Pages: 68-72

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of an inducible factor secreted by pan-creatic cancer cell 1ines that stimulates the producti-on of fucosylated haptoglobin in hepatoma cells.2008

    • Author(s)
      Narisada Megumi
    • Journal Title

      Biochemica1 and Biophysical Research Communications 377

      Pages: 792-796

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] "難治性C型肝炎に対する新薬開発を踏まえたPeg-IFN/Ribavirin併用療法の適応と限界"パネルディスカッション「C型肝炎に対する新たな治療戦略」2010

    • Author(s)
      平松直樹
    • Organizer
      JDDW2010(第18回日本消化器関連学会週間)
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2010-10-14
    • Related Report
      2010 Annual Research Report
  • [Presentation] 難治性C型肝炎に対する新薬開発を踏まえたPeg-IFN/Ribavirin併用療法の適応と限界"パネルディスカッション「C型肝炎に対する新たな治療戦略」、JDDW20102010

    • Author(s)
      平松直樹
    • Organizer
      第18回日本消化器関連学会週間
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2010-10-13
    • Related Report
      2010 Final Research Report
  • [Presentation] 難治性C型肝炎に対するPeg-IFN/Ribavirin併用療法の個別化治療による治療効果改善の可能性"シンポジウム「C型肝炎における抗ウイルス療法の近未来」2010

    • Author(s)
      平松直樹
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      ホテルメトロポリタン山形
    • Year and Date
      2010-05-27
    • Related Report
      2010 Final Research Report
  • [Presentation] 糖転移酵素N-アセチルグルコサミン転移酵素V(GnT-V)は肝線維化を抑制する2010

    • Author(s)
      森華奈子、三善英知
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      ホテルメトロポリタン山形
    • Year and Date
      2010-05-27
    • Related Report
      2010 Final Research Report
  • [Presentation] 糖転移酵素 N-アセチルグルコサミン転移酵素 V(GnT-V)は肝線維化を抑制する2010

    • Author(s)
      森華奈子、三善英知
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      ホテルメトロポリタン山形
    • Year and Date
      2010-05-27
    • Related Report
      2010 Annual Research Report
  • [Presentation] "難治性C型肝炎に対するPeg-IFN/Ribavirin併用療法の個別化治療による治療効果改善の可能性"シンポジウム「C型肝炎における抗ウイルス療法の近未来」2010

    • Author(s)
      平松直樹
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      ホテルメトロポリタン山形
    • Year and Date
      2010-05-27
    • Related Report
      2010 Annual Research Report
  • [Presentation] C型慢性肝炎に対するpeg-IFN+RBV併用無効例に対する方策難治性C型肝炎に対するPeg-IFN/RBV併用療法における非著効例への方策 多施設(OLF)共同研究(会議録)2009

    • Author(s)
      小瀬嗣子, 平松直樹
    • Organizer
      第13回日本肝臓学会大会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2009-10-15
    • Related Report
      2010 Final Research Report
  • [Presentation] C型慢性肝炎に対するpeg-IFN+RBV併用無効例に対する方策 難治性C型肝炎に対するPeg-IFN/RBV併用療法における非著効例への方策 多施設 (OLF) 共同研究 (会議録)2009

    • Author(s)
      小瀬嗣子, 平松直樹
    • Organizer
      第13回日本肝臓学会大会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2009-10-15
    • Related Report
      2009 Annual Research Report
  • [Presentation] C型肝炎に対する治療方針のコンセンサス2009

    • Author(s)
      平松直樹
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸国際会議場
    • Year and Date
      2009-06-05
    • Related Report
      2010 Final Research Report 2009 Annual Research Report
  • [Presentation] 糖転移酵素N-アセチルグルコサミン転移酵素V(GnT-V)は肝星細胞におけるコラーゲンIの遺伝子発現を抑制する2009

    • Author(s)
      森華奈子、三善英知
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸国際会議場
    • Year and Date
      2009-06-05
    • Related Report
      2010 Final Research Report
  • [Presentation] 糖転移酵素N-アセチルグルコサミン転移酵素 V(GnT-V) は肝星細胞におけるコラーゲンIの遺伝子発現を抑制する2009

    • Author(s)
      森華奈子, 三善英知
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸国際会議場
    • Year and Date
      2009-06-05
    • Related Report
      2009 Annual Research Report
  • [Presentation] 分子シャペロンORP150は肝癌細胞株において脂肪酸負荷による小胞体ストレスを軽減し、アポトーシスを抑制する。2008

    • Author(s)
      松本 仁
    • Organizer
      第16回日本消化器関連学会週間
    • Place of Presentation
      東京
    • Year and Date
      2008-10-02
    • Related Report
      2008 Annual Research Report
  • [Presentation] 分子シャペロンORP150は肝癌細胞株において脂肪酸負荷による小胞体ストレスに起因するアポトーシスを抑制する2008

    • Author(s)
      松本 仁
    • Organizer
      第44回肝臓学会総会
    • Place of Presentation
      松山
    • Year and Date
      2008-06-06
    • Related Report
      2008 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi